Moderna says it’s suing Pfizer, Biontech over Covid-19 shots
Moderna said it’s suing Pfizer and Biontech, claiming the technology in the partners’ Covid-19 shot infringes on its patents, a move that sets the stage for a massive legal clash between the three vaccine titans.
By Angelica Peebles and Robert Langreth, bloomberg
Moderna, in a statement Friday, accused Pfizer Inc. and Biontech SE of violating intellectual property protecting key elements of Moderna’s messenger RNA technology in developing the Comirnaty vaccine. Cambridge, Massachusetts-based Moderna said it had patents from 2010 to 2016 on the mRNA technology that made its Spikevax shot possible but that the other two companies copied the technology without permission.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pfizer to submit RSV vaccine for FDA approval in fall
For subscribers
Novavax's Covid-19 vaccine backed by CDC experts
For subscribers
Genmab and Biontech expand their partnership
For subscribers
